Monoclonal antibodies (mAbs) have revolutionized modern medicine, offering precision therapies for cancer, autoimmune disorders, infectious diseases, and numerous other advantages. The global mAb ...

Syngene posted its financials for the third quarter on 22 January, with revenue and profit missing estimates.(AFP) Contract drug research and manufacturing firm Syngene International Ltd has lowered ...

Johnson & Johnson expands its Tar Heel State presence with $2 billion investment, and Syngene sites first U.S. facility in Baltimore. Johnson & Johnson is expanding its footprint in North Carolina ...

DUBLIN--(BUSINESS WIRE)--The "Cytotoxic Drugs & HPAPI Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Product, Company Size, Scale of Operation, Type of Molecule, Type of ...